336 related articles for article (PubMed ID: 18154533)
1. Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective.
Rodríguez-Baño J; Navarro MD
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():104-10. PubMed ID: 18154533
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of extended-spectrum beta-lactamases.
Rodríguez-Baño J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):671-83. PubMed ID: 18847405
[TBL] [Abstract][Full Text] [Related]
4. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Rodríguez-Baño J; Picón E; Gijón P; Hernández JR; Ruíz M; Peña C; Almela M; Almirante B; Grill F; Colomina J; Giménez M; Oliver A; Horcajada JP; Navarro G; Coloma A; Pascual A;
Clin Infect Dis; 2010 Jan; 50(1):40-8. PubMed ID: 19995215
[TBL] [Abstract][Full Text] [Related]
5. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
6. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamases in long-term-care facilities.
Nicolas-Chanoine MH; Jarlier V;
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():111-6. PubMed ID: 18154534
[TBL] [Abstract][Full Text] [Related]
9. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamase-producing organisms.
Falagas ME; Karageorgopoulos DE
J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
[TBL] [Abstract][Full Text] [Related]
11. Addressing the challenge of extended-spectrum beta-lactamases.
Zahar JR; Lortholary O; Martin C; Potel G; Plesiat P; Nordmann P
Curr Opin Investig Drugs; 2009 Feb; 10(2):172-80. PubMed ID: 19197795
[TBL] [Abstract][Full Text] [Related]
12. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
[TBL] [Abstract][Full Text] [Related]
13. CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.
Celik AD; Yulugkural Z; Kuloglu F; Eroglu C; Torol S; Vahaboğlu H; Akata F
J Microbiol Immunol Infect; 2010 Apr; 43(2):163-7. PubMed ID: 20457435
[TBL] [Abstract][Full Text] [Related]
14. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women.
Ho PL; Poon WW; Loke SL; Leung MS; Chow KH; Wong RC; Yip KS; Lai EL; Tsang KW;
J Antimicrob Chemother; 2007 Jul; 60(1):140-4. PubMed ID: 17496058
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli.
Wu UI; Yang CS; Chen WC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):310-6. PubMed ID: 20688291
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.
Peirano G; Pitout JD
Int J Antimicrob Agents; 2010 Apr; 35(4):316-21. PubMed ID: 20060273
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.
Cantón R; Novais A; Valverde A; Machado E; Peixe L; Baquero F; Coque TM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():144-53. PubMed ID: 18154538
[TBL] [Abstract][Full Text] [Related]
19. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
[TBL] [Abstract][Full Text] [Related]
20. Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Park SH; Choi SM; Lee DG; Kim J; Choi JH; Kim SH; Kwon JC; Yoo JH
Microb Drug Resist; 2011 Dec; 17(4):537-44. PubMed ID: 21875342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
